SAN JOSE, Calif.--(BUSINESS WIRE)--NewCardio, Inc. (OTCBB: NWCI), a development-stage cardiac diagnostic and services company, announced today that it has received a Certificate of Grant from the European Patent Office covering CardioBip™, its proprietary device and methodology for transtelephonic transmission of comprehensive ECG data.
